K. Havemann

402 total citations
25 papers, 292 citations indexed

About

K. Havemann is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Immunology. According to data from OpenAlex, K. Havemann has authored 25 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in K. Havemann's work include Blood properties and coagulation (9 papers), Protease and Inhibitor Mechanisms (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). K. Havemann is often cited by papers focused on Blood properties and coagulation (9 papers), Protease and Inhibitor Mechanisms (6 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). K. Havemann collaborates with scholars based in Germany, United States and Egypt. K. Havemann's co-authors include M. Gramse, R. Egbring, Gerald Kolb, Rainer Seitz, W Schmidt, Gabriele Jaques, Alan Solomon, Ulrich Kaiser, C. Gropp and Paul Kiefer and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

K. Havemann

23 papers receiving 268 citations

Peers

K. Havemann
Comparison fields: 5 of 65
  • Hematology 84
  • Pulmonary and Respiratory Medicine 77
  • Molecular Biology 60
  • Cancer Research 53
  • Epidemiology 51
Replace P Lutz with:
P Lutz France
C Linthorst Netherlands
Stig Gustavsson
Panagiota Matsouka Greece
Melody Campbell United States
Richard S. Bornstein United States
Ajay Bapna India
Charlotte Delarche France
Habib M. Ghaddar United States
Hidekazu Kamitsuji Japan
P Lutz France View profile →
Citations per field, relative to K. Havemann
K. Havemann · 1×
Citations per year, relative to K. Havemann
K. Havemann · 1×

Countries citing papers authored by K. Havemann

Since Specialization
Citations

This map shows the geographic impact of K. Havemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Havemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Havemann more than expected).

Fields of papers citing papers by K. Havemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Havemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Havemann. The network helps show where K. Havemann may publish in the future.

Co-authorship network of co-authors of K. Havemann

This figure shows the co-authorship network connecting the top 25 collaborators of K. Havemann. A scholar is included among the top collaborators of K. Havemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Havemann. K. Havemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 11
2 14
3 53
4 8
5 1
6 2
7 24
8 8
9
Neutrophil function in patients with localized juvenile periodontitis and with rapidly progressive periodontitis.
12
10
[Determination of the ELP (elastase-like proteinase) plasma levels in patients with rapidly advancing and with juvenile periodontitis].
1
11
[Arterial thromboses as a complication of Whipple disease].
1
12
[Acute malignant myelofibrosis complicated by factor XIII deficiency, protein C decrease and skin necroses].
0
13 6
14 1
15
A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. 2. Inhibition of human leukocyte elastase and cathepsin G by anti-inflammatory drugs.
11
16 15
17 5
18 2
19 22
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026